These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 18561175
21. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients. Warkentin DI, Epstein JB, Campbell LM, Yip JG, Cox VC, Ransier A, Barnett MJ, Marra F. Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600 [Abstract] [Full Text] [Related]
22. A case series using famciclovir in stem cell transplant recipients with valacyclovir hypersensitivity reactions. Shah SA, Gulbis A, Wilhelm K. J Oncol Pharm Pract; 2015 Aug; 21(4):305-9. PubMed ID: 24714130 [Abstract] [Full Text] [Related]
23. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O. Cochrane Database Syst Rev; 2014 Aug 03; 2014(8):CD009036. PubMed ID: 25086573 [Abstract] [Full Text] [Related]
24. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses. Garré B, Shebany K, Gryspeerdt A, Baert K, van der Meulen K, Nauwynck H, Deprez P, De Backer P, Croubels S. Antimicrob Agents Chemother; 2007 Dec 03; 51(12):4308-14. PubMed ID: 17846132 [Abstract] [Full Text] [Related]
25. A new paediatric formulation of valaciclovir: development and bioequivalence assessment. Bastiaans DE, Bartels-Wilmer CM, Colbers AP, Heijens CA, Velthoven-Graafland K, Smeets OS, Vink N, Harbers VE, Warris A, Burger DM. Arch Dis Child; 2016 Oct 03; 101(10):971-2. PubMed ID: 27162003 [No Abstract] [Full Text] [Related]
26. Valacyclovir as Initial Treatment for Acute Retinal Necrosis: A Pharmacokinetic Modeling and Simulation Study. Liu T, Jain A, Fung M, Vinnard C, Ivaturi V. Curr Eye Res; 2017 Jul 03; 42(7):1035-1038. PubMed ID: 28358222 [Abstract] [Full Text] [Related]
27. Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy. Wang LH, Schultz M, Weller S, Smiley ML, Blum MR. Antimicrob Agents Chemother; 1996 Jan 03; 40(1):80-5. PubMed ID: 8787884 [Abstract] [Full Text] [Related]
28. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial. Tyring SK, Plunkett S, Scribner AR, Broker RE, Herrod JN, Handke LT, Wise JM, Martin PA, Valomaciclovir Zoster Study Group. J Med Virol; 2012 Aug 03; 84(8):1224-32. PubMed ID: 22711350 [Abstract] [Full Text] [Related]
29. Pharmacology of new antiherpes agents: famciclovir and valacyclovir. Stein GE. J Am Pharm Assoc (Wash); 1997 Aug 03; NS37(2):157-63. PubMed ID: 9069689 [Abstract] [Full Text] [Related]
30. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness. Simon MW, Fish DN, Deeter RG. Drugs R D; 2002 Aug 03; 3(6):365-73. PubMed ID: 12516939 [Abstract] [Full Text] [Related]
31. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections. Wu JJ, Brentjens MH, Torres G, Yeung-Yue K, Lee P, Tyring SK. J Cutan Med Surg; 2003 Aug 03; 7(5):372-81. PubMed ID: 14505192 [Abstract] [Full Text] [Related]
32. Valacyclovir. Acosta EP, Fletcher CV. Ann Pharmacother; 1997 Feb 03; 31(2):185-91. PubMed ID: 9034421 [Abstract] [Full Text] [Related]
33. Extrapolation of Valacyclovir Posology to Children Based on Pharmacokinetic Modeling. Kechagia IA, Kalantzi L, Dokoumetzidis A. Pediatr Infect Dis J; 2015 Dec 03; 34(12):1342-8. PubMed ID: 26379165 [Abstract] [Full Text] [Related]
34. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo BJ. Antimicrob Agents Chemother; 2003 Jul 03; 47(7):2351-3. PubMed ID: 12821497 [Abstract] [Full Text] [Related]
35. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T. Ophthalmology; 2000 Aug 03; 107(8):1507-11. PubMed ID: 10919899 [Abstract] [Full Text] [Related]
36. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Warren T, Harris J, Brennan CA. Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897 [Abstract] [Full Text] [Related]
37. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Baker D, Eisen D. Cutis; 2003 Mar 01; 71(3):239-42. PubMed ID: 12661753 [Abstract] [Full Text] [Related]
38. FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial. Tyring SK, Lee P, Hill GT, Silverfield JC, Moore AY, Matkovits T, Sullivan-Bolyai J. J Med Virol; 2017 Jul 01; 89(7):1255-1264. PubMed ID: 27943311 [Abstract] [Full Text] [Related]
39. Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia. Orlowski RZ, Mills SR, Hartley EE, Ye X, Piantadosi S, Ambinder RF, Gore SD, Miller CB. Leuk Lymphoma; 2004 Nov 01; 45(11):2215-9. PubMed ID: 15512809 [Abstract] [Full Text] [Related]
40. Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study. Izzedine H, Mercadal L, Aymard G, Launay-Vacher V, Martinez V, Issad B, Deray G. Am J Nephrol; 2001 Nov 01; 21(2):162-4. PubMed ID: 11359026 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]